Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

Lalitha L. Menon, Beatrice Chin, Muhammad A. Khattak

Research output: Contribution to journal › Letter

Cite this

@article{d7c5cbdded8043ecb39db3a1d99e959a,

title = "Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)",

author = "Menon, {Lalitha L.} and Beatrice Chin and Khattak, {Muhammad A.}",

year = "2018",

month = dec,

day = "1",

doi = "10.1111/imj.14131",

language = "English",

volume = "48",

pages = "1542--1543",

journal = "Internal Medicine Journal (Print)",

issn = "1444-0903",

publisher = "John Wiley & Sons",

number = "12",

}

TY - JOUR

T1 - Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

AU - Menon, Lalitha L.

AU - Chin, Beatrice

AU - Khattak, Muhammad A.

PY - 2018/12/1

Y1 - 2018/12/1

UR - http://www.scopus.com/inward/record.url?scp=85057739247&partnerID=8YFLogxK

U2 - 10.1111/imj.14131

DO - 10.1111/imj.14131

M3 - Letter

C2 - 30517998

AN - SCOPUS:85057739247

VL - 48

SP - 1542

EP - 1543

JO - Internal Medicine Journal (Print)

JF - Internal Medicine Journal (Print)

SN - 1444-0903

IS - 12

ER -